Lexicon Pharmaceuticals, Inc.

NASDAQ:LXRX

1.19 (USD) • At close November 12, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999
Omzet 1.2040.1390.29823.995322.07363.20990.33583.337130.01422.8542.2221.0891.8494.90810.732.32150.11872.79875.6861.7442.83835.2305.57714.4594.7
Kosten van de omzet 0.6390.42755.0461.9293.2312.4911.899163.97395.18789.27989.68282.57400000000000-2.621-2
Brutowinst 0.565-0.288-54.74822.066318.84260.71888.436-80.63634.827-66.425-87.46-81.4851.8494.90810.732.32150.11872.79875.6861.7442.83835.2305.57717.086.7
Brutowinstmarge 0.469-2.072-183.7180.920.990.9610.979-0.9680.268-2.906-39.361-74.826111111111111.1811.426
Onderzoek- en ontwikkelingskosten 58.33352.81655.046153.62191.924100.243156.813178.15195.18789.27989.68282.57491.82875.3581.238108.575104.332106.69593.62590.58682.19874.85953.35531.64714.6
Algemene en administratieve kosten 048.08300063.75466.20343.04423.83519.41117.12117.04317.3522.56619.41820.28120.7421.334000020.86118.2890
Verkoop- en marketingkosten 0000000000000000000000000
Verkoop-, algemene en administratieve kosten 113.98248.08332.34247.2356.83563.75466.20343.04423.83519.41117.12117.04317.3522.56619.41820.28120.7421.33418.17418.60823.23323.23420.86118.2892.9
Overige kosten -58.887001.628.63801.9542.2930.5722.2550.0590.10524.1162.71020.28120.7421.33418.17418.60823.23323.2342752.6214.9
Bedrijfskosten 172.315100.89987.388200.851148.759163.997223.016221.195119.022108.69106.80399.617115.944100.626100.656128.856125.072128.029111.799109.194105.43198.093349.21652.55619.5
Bedrijfsresultaat -171.75-100.76-87.09-178.785141.445-103.279-136.681-137.1551.468-100.366-102.371-108.415-114.095-95.718-89.956-96.535-74.954-55.231-36.119-47.454-62.593-62.893-43.639-35.477-12.8
Bedrijfsresultaat ratio -142.65-724.892-292.248-7.4510.439-1.634-1.513-1.6460.011-4.392-46.072-99.555-61.706-19.502-8.407-2.987-1.496-0.759-0.477-0.769-1.461-1.787-0.143-2.454-2.723
Totaal overige inkomsten en kosten netto -5.369-1.184-0.668-10.774-17.326-17.269-5.03-4.274-6.150.002-1.755-1.796-2.12-6.083-3.463-0.3493.7210.801-0.0770.28200000
Inkomen voor belasting -177.119-101.944-87.758-58.574124.119-120.548-141.711-141.429-4.682-100.364-104.126-110.211-116.215-101.801-93.419-96.884-71.23354.4339.196-46.1500000
Inkomen voor belasting ratio -147.109-733.41-294.49-2.4410.385-1.907-1.569-1.697-0.036-4.392-46.861-101.204-62.853-20.742-8.731-2.998-1.4210.7480.518-0.74700000
Belastingkosten 0.3861.1840.5111.61-6.0143.508-12.6614.5115.995-0.07-0.833-1.971-2.359-0.026-0.102-19.675-16.16-0.1190.119-0.2821.605-3.223-8.467-9.483-0.3
Nettowinst -177.119-103.128-88.268-70.184130.133-120.548-129.05-141.429-4.682-100.294-104.126-110.211-116.215-101.775-82.78-76.86-58.794-54.311-36.315-47.172-64.198-59.67-35.172-25.994-12.5
Nettowinstmarge -147.109-741.928-296.201-2.9250.404-1.907-1.429-1.697-0.036-4.388-46.861-101.204-62.853-20.737-7.736-2.378-1.173-0.746-0.48-0.764-1.499-1.695-0.115-1.798-2.66
WPA (Winst Per Aandeel) -0.8-0.62-0.61-0.631.23-1.14-1.23-1.36-0.045-1.31-1.42-1.58-2.39-2.35-3.98-3.93-4.12-5.68-3.97-5.21-7.91-7.99-4.9-4.37-3.57
Verwaterde WPA -0.8-0.62-0.61-0.631.11-1.14-1.23-1.36-0.045-1.31-1.42-1.58-2.39-2.35-3.98-3.93-4.12-5.68-3.97-5.21-7.91-7.99-4.9-4.37-3.57
EBITDA -163.464-98.737-86.664-41.096173.737-96.088-125.271-125.81811.719-96.183-99.292-103.907-108.8-93.688-84.294-86.264-64.532-39.976-24.484-34.582-41.063-42.314-27.089-32.856-10.8
EBITDA ratio -142.189-713.41-291.799-7.3360.538-1.578-1.468-1.6270.089-3.657-46.969-90.184-61.568-19.397-8.325-2.569-1.272-0.61-0.331-0.581-0.959-1.202-0.089-2.272-2.298